Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MediWound (MDWD) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for MediWound (MDWD) over the last 13 years, with Q3 2025 value amounting to 49.01%.

  • MediWound's EBITDA Margin rose 1872400.0% to 49.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 28.85%, marking a year-over-year increase of 1072500.0%. This contributed to the annual value of 149.43% for FY2024, which is 1134200.0% down from last year.
  • Latest data reveals that MediWound reported EBITDA Margin of 49.01% as of Q3 2025, which was up 1872400.0% from 233.51% recorded in Q2 2025.
  • MediWound's 5-year EBITDA Margin high stood at 233.51% for Q2 2025, and its period low was 236.26% during Q3 2024.
  • Its 5-year average for EBITDA Margin is 37.87%, with a median of 52.39% in 2021.
  • Its EBITDA Margin has fluctuated over the past 5 years, first tumbled by -1904200bps in 2024, then soared by 1872400bps in 2025.
  • MediWound's EBITDA Margin (Quarter) stood at 75.71% in 2021, then rose by 15bps to 64.36% in 2022, then soared by 49bps to 32.86% in 2023, then tumbled by -103bps to 66.85% in 2024, then rose by 27bps to 49.01% in 2025.
  • Its EBITDA Margin was 49.01% in Q3 2025, compared to 233.51% in Q2 2025 and 18.33% in Q1 2025.